122 related articles for article (PubMed ID: 38013666)
21. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
23. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells.
Mukherjee K; Syed V; Ho SM
Oncogene; 2005 Jun; 24(27):4388-400. PubMed ID: 15806153
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Africander D; Louw R; Verhoog N; Noeth D; Hapgood JP
Contraception; 2011 Oct; 84(4):423-35. PubMed ID: 21920200
[TBL] [Abstract][Full Text] [Related]
27. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.
Zhou J; Yu Q; Chen R; Seeger H; Fehm T; Cahill MA; Mueck AO; Neubauer H
Maturitas; 2013 Oct; 76(2):129-33. PubMed ID: 23856385
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
29. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
30. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention.
Rodriguez GC; Turbov J; Rosales R; Yoo J; Hunn J; Zappia KJ; Lund K; Barry CP; Rodriguez IV; Pike JW; Conrads TP; Darcy KM; Maxwell GL; Hamilton CA; Syed V; Thaete LG
Gynecol Oncol; 2016 Oct; 143(1):159-167. PubMed ID: 27106018
[TBL] [Abstract][Full Text] [Related]
31. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.
Zuo L; Li W; You S
Breast Cancer Res; 2010; 12(3):R34. PubMed ID: 20540763
[TBL] [Abstract][Full Text] [Related]
32. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.
Classen S; Possinger K; Pelka-Fleischer R; Wilmanns W
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):315-9. PubMed ID: 8499339
[TBL] [Abstract][Full Text] [Related]
33. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
[TBL] [Abstract][Full Text] [Related]
34. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
Hu Q; Yu L; Chen R; Wang YL; Ji L; Zhang Y; Xie Y; Liao QP
Int J Gynecol Cancer; 2012 Jul; 22(6):951-9. PubMed ID: 22683940
[TBL] [Abstract][Full Text] [Related]
35. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
36. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
37. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
38. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
39. [Study on the treatment of high dose mifepristone and progesterone in endometrial carcinoma].
Li CZ; Wen ZQ; Lan SM; Wang JY; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):552-5. PubMed ID: 14680611
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
